REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Henson Farma (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: PT Henson Farma Profile Updated: February 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

PT Henson Farma is a company based in Indonesia, with its head office in Surabaya. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on March 29, 1977. There are currently 300 (estimated) people employed by PT Henson Farma. From the latest financial highlights, PT Henson Farma reported a net sales revenue increase of 17.1% in 2022. Its’ total assets recorded a growth of 18.22%.

Headquarters
RT 004 RW 003
Surabaya; East Java; Postal Code: 60221

Contact Details: Purchase the PT Henson Farma report to view the information.

Website: http://www.hensonfarma.id

Basic Information
Total Employees:
Purchase the PT Henson Farma report to view the information.
Outstanding Shares:
Purchase the PT Henson Farma report to view the information.
Registered Capital:
Purchase the PT Henson Farma report to view the information.
Incorporation Date:
March 29, 1977
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Henson Farma report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
17.1%
Total operating revenue
17.1%
Total assets
18.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?